Global Nucleic Acid-Based Diagnostic Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 86
Inquire Before Buying

Nucleic Acid-Based Diagnostic market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nucleic Acid-Based Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Nucleic Acid Molecular Hybridization

- Polymerase Chain Reaction

- Thermostatic Amplification

- Gene Sequencing

- Biochip Technology

Segment by Application

- Hospital

- Clinical Laboratory

- Research Institutions

- Clinic

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Agilent Technologies

- Danaher Corporation

- Abbott Laboratories

- BD

- Bio-Rad Laboratories

- Roche

- Illumina, Inc

- Thermo Fisher Scientific Inc.

- Merck KGaA

- Qiagen

Global Nucleic Acid-Based Diagnostic Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid-Based Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Nucleic Acid Molecular Hybridization
1.2.3 Polymerase Chain Reaction
1.2.4 Thermostatic Amplification
1.2.5 Gene Sequencing
1.2.6 Biochip Technology
1.3 Market by Application
1.3.1 Global Nucleic Acid-Based Diagnostic Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinical Laboratory
1.3.4 Research Institutions
1.3.5 Clinic
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid-Based Diagnostic Market Perspective (2017-2028)
2.2 Nucleic Acid-Based Diagnostic Growth Trends by Region
2.2.1 Nucleic Acid-Based Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nucleic Acid-Based Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Nucleic Acid-Based Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Nucleic Acid-Based Diagnostic Market Dynamics
2.3.1 Nucleic Acid-Based Diagnostic Industry Trends
2.3.2 Nucleic Acid-Based Diagnostic Market Drivers
2.3.3 Nucleic Acid-Based Diagnostic Market Challenges
2.3.4 Nucleic Acid-Based Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid-Based Diagnostic Players by Revenue
3.1.1 Global Top Nucleic Acid-Based Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Nucleic Acid-Based Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Nucleic Acid-Based Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid-Based Diagnostic Revenue
3.4 Global Nucleic Acid-Based Diagnostic Market Concentration Ratio
3.4.1 Global Nucleic Acid-Based Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-Based Diagnostic Revenue in 2021
3.5 Nucleic Acid-Based Diagnostic Key Players Head office and Area Served
3.6 Key Players Nucleic Acid-Based Diagnostic Product Solution and Service
3.7 Date of Enter into Nucleic Acid-Based Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid-Based Diagnostic Breakdown Data by Type
4.1 Global Nucleic Acid-Based Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Nucleic Acid-Based Diagnostic Forecasted Market Size by Type (2023-2028)
5 Nucleic Acid-Based Diagnostic Breakdown Data by Application
5.1 Global Nucleic Acid-Based Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Nucleic Acid-Based Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nucleic Acid-Based Diagnostic Market Size (2017-2028)
6.2 North America Nucleic Acid-Based Diagnostic Market Size by Country (2017-2022)
6.3 North America Nucleic Acid-Based Diagnostic Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nucleic Acid-Based Diagnostic Market Size (2017-2028)
7.2 Europe Nucleic Acid-Based Diagnostic Market Size by Country (2017-2022)
7.3 Europe Nucleic Acid-Based Diagnostic Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid-Based Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Nucleic Acid-Based Diagnostic Market Size by Country (2017-2022)
8.3 Asia-Pacific Nucleic Acid-Based Diagnostic Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nucleic Acid-Based Diagnostic Market Size (2017-2028)
9.2 Latin America Nucleic Acid-Based Diagnostic Market Size by Country (2017-2022)
9.3 Latin America Nucleic Acid-Based Diagnostic Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid-Based Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Nucleic Acid-Based Diagnostic Market Size by Country (2017-2022)
10.3 Middle East & Africa Nucleic Acid-Based Diagnostic Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Nucleic Acid-Based Diagnostic Introduction
11.1.4 Agilent Technologies Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022)
11.1.5 Agilent Technologies Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Detail
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Nucleic Acid-Based Diagnostic Introduction
11.2.4 Danaher Corporation Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022)
11.2.5 Danaher Corporation Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Nucleic Acid-Based Diagnostic Introduction
11.3.4 Abbott Laboratories Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022)
11.3.5 Abbott Laboratories Recent Development
11.4 BD
11.4.1 BD Company Detail
11.4.2 BD Business Overview
11.4.3 BD Nucleic Acid-Based Diagnostic Introduction
11.4.4 BD Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022)
11.4.5 BD Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Nucleic Acid-Based Diagnostic Introduction
11.5.4 Bio-Rad Laboratories Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Nucleic Acid-Based Diagnostic Introduction
11.6.4 Roche Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022)
11.6.5 Roche Recent Development
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Detail
11.7.2 Illumina, Inc Business Overview
11.7.3 Illumina, Inc Nucleic Acid-Based Diagnostic Introduction
11.7.4 Illumina, Inc Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022)
11.7.5 Illumina, Inc Recent Development
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Detail
11.8.2 Thermo Fisher Scientific Inc. Business Overview
11.8.3 Thermo Fisher Scientific Inc. Nucleic Acid-Based Diagnostic Introduction
11.8.4 Thermo Fisher Scientific Inc. Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022)
11.8.5 Thermo Fisher Scientific Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Nucleic Acid-Based Diagnostic Introduction
11.9.4 Merck KGaA Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022)
11.9.5 Merck KGaA Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Nucleic Acid-Based Diagnostic Introduction
11.10.4 Qiagen Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022)
11.10.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Nucleic Acid-Based Diagnostic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Nucleic Acid Molecular Hybridization
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Thermostatic Amplification
Table 5. Key Players of Gene Sequencing
Table 6. Key Players of Biochip Technology
Table 7. Global Nucleic Acid-Based Diagnostic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Nucleic Acid-Based Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Nucleic Acid-Based Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Nucleic Acid-Based Diagnostic Market Share by Region (2017-2022)
Table 11. Global Nucleic Acid-Based Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Nucleic Acid-Based Diagnostic Market Share by Region (2023-2028)
Table 13. Nucleic Acid-Based Diagnostic Market Trends
Table 14. Nucleic Acid-Based Diagnostic Market Drivers
Table 15. Nucleic Acid-Based Diagnostic Market Challenges
Table 16. Nucleic Acid-Based Diagnostic Market Restraints
Table 17. Global Nucleic Acid-Based Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Nucleic Acid-Based Diagnostic Market Share by Players (2017-2022)
Table 19. Global Top Nucleic Acid-Based Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-Based Diagnostic as of 2021)
Table 20. Ranking of Global Top Nucleic Acid-Based Diagnostic Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Nucleic Acid-Based Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nucleic Acid-Based Diagnostic Product Solution and Service
Table 24. Date of Enter into Nucleic Acid-Based Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nucleic Acid-Based Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Nucleic Acid-Based Diagnostic Revenue Market Share by Type (2017-2022)
Table 28. Global Nucleic Acid-Based Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Nucleic Acid-Based Diagnostic Revenue Market Share by Type (2023-2028)
Table 30. Global Nucleic Acid-Based Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Nucleic Acid-Based Diagnostic Revenue Market Share by Application (2017-2022)
Table 32. Global Nucleic Acid-Based Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Nucleic Acid-Based Diagnostic Revenue Market Share by Application (2023-2028)
Table 34. North America Nucleic Acid-Based Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Nucleic Acid-Based Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Nucleic Acid-Based Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Nucleic Acid-Based Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Nucleic Acid-Based Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Nucleic Acid-Based Diagnostic Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Nucleic Acid-Based Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Nucleic Acid-Based Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Nucleic Acid-Based Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Nucleic Acid-Based Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 44. Agilent Technologies Company Detail
Table 45. Agilent Technologies Business Overview
Table 46. Agilent Technologies Nucleic Acid-Based Diagnostic Product
Table 47. Agilent Technologies Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022) & (US$ Million)
Table 48. Agilent Technologies Recent Development
Table 49. Danaher Corporation Company Detail
Table 50. Danaher Corporation Business Overview
Table 51. Danaher Corporation Nucleic Acid-Based Diagnostic Product
Table 52. Danaher Corporation Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022) & (US$ Million)
Table 53. Danaher Corporation Recent Development
Table 54. Abbott Laboratories Company Detail
Table 55. Abbott Laboratories Business Overview
Table 56. Abbott Laboratories Nucleic Acid-Based Diagnostic Product
Table 57. Abbott Laboratories Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022) & (US$ Million)
Table 58. Abbott Laboratories Recent Development
Table 59. BD Company Detail
Table 60. BD Business Overview
Table 61. BD Nucleic Acid-Based Diagnostic Product
Table 62. BD Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022) & (US$ Million)
Table 63. BD Recent Development
Table 64. Bio-Rad Laboratories Company Detail
Table 65. Bio-Rad Laboratories Business Overview
Table 66. Bio-Rad Laboratories Nucleic Acid-Based Diagnostic Product
Table 67. Bio-Rad Laboratories Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022) & (US$ Million)
Table 68. Bio-Rad Laboratories Recent Development
Table 69. Roche Company Detail
Table 70. Roche Business Overview
Table 71. Roche Nucleic Acid-Based Diagnostic Product
Table 72. Roche Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022) & (US$ Million)
Table 73. Roche Recent Development
Table 74. Illumina, Inc Company Detail
Table 75. Illumina, Inc Business Overview
Table 76. Illumina, Inc Nucleic Acid-Based Diagnostic Product
Table 77. Illumina, Inc Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022) & (US$ Million)
Table 78. Illumina, Inc Recent Development
Table 79. Thermo Fisher Scientific Inc. Company Detail
Table 80. Thermo Fisher Scientific Inc. Business Overview
Table 81. Thermo Fisher Scientific Inc. Nucleic Acid-Based Diagnostic Product
Table 82. Thermo Fisher Scientific Inc. Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022) & (US$ Million)
Table 83. Thermo Fisher Scientific Inc. Recent Development
Table 84. Merck KGaA Company Detail
Table 85. Merck KGaA Business Overview
Table 86. Merck KGaA Nucleic Acid-Based Diagnostic Product
Table 87. Merck KGaA Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022) & (US$ Million)
Table 88. Merck KGaA Recent Development
Table 89. Qiagen Company Detail
Table 90. Qiagen Business Overview
Table 91. Qiagen Nucleic Acid-Based Diagnostic Product
Table 92. Qiagen Revenue in Nucleic Acid-Based Diagnostic Business (2017-2022) & (US$ Million)
Table 93. Qiagen Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid-Based Diagnostic Market Share by Type: 2021 VS 2028
Figure 2. Nucleic Acid Molecular Hybridization Features
Figure 3. Polymerase Chain Reaction Features
Figure 4. Thermostatic Amplification Features
Figure 5. Gene Sequencing Features
Figure 6. Biochip Technology Features
Figure 7. Global Nucleic Acid-Based Diagnostic Market Share by Application in 2021 & 2028
Figure 8. Hospital Case Studies
Figure 9. Clinical Laboratory Case Studies
Figure 10. Research Institutions Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Nucleic Acid-Based Diagnostic Report Years Considered
Figure 14. Global Nucleic Acid-Based Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Nucleic Acid-Based Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Nucleic Acid-Based Diagnostic Market Share by Region: 2021 VS 2028
Figure 17. Global Nucleic Acid-Based Diagnostic Market Share by Players in 2021
Figure 18. Global Top Nucleic Acid-Based Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-Based Diagnostic as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Nucleic Acid-Based Diagnostic Revenue in 2021
Figure 20. North America Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Nucleic Acid-Based Diagnostic Market Share by Country (2017-2028)
Figure 22. United States Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Nucleic Acid-Based Diagnostic Market Share by Country (2017-2028)
Figure 26. Germany Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Nucleic Acid-Based Diagnostic Market Share by Region (2017-2028)
Figure 34. China Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Nucleic Acid-Based Diagnostic Market Share by Country (2017-2028)
Figure 42. Mexico Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Nucleic Acid-Based Diagnostic Market Share by Country (2017-2028)
Figure 46. Turkey Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Nucleic Acid-Based Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Agilent Technologies Revenue Growth Rate in Nucleic Acid-Based Diagnostic Business (2017-2022)
Figure 49. Danaher Corporation Revenue Growth Rate in Nucleic Acid-Based Diagnostic Business (2017-2022)
Figure 50. Abbott Laboratories Revenue Growth Rate in Nucleic Acid-Based Diagnostic Business (2017-2022)
Figure 51. BD Revenue Growth Rate in Nucleic Acid-Based Diagnostic Business (2017-2022)
Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Nucleic Acid-Based Diagnostic Business (2017-2022)
Figure 53. Roche Revenue Growth Rate in Nucleic Acid-Based Diagnostic Business (2017-2022)
Figure 54. Illumina, Inc Revenue Growth Rate in Nucleic Acid-Based Diagnostic Business (2017-2022)
Figure 55. Thermo Fisher Scientific Inc. Revenue Growth Rate in Nucleic Acid-Based Diagnostic Business (2017-2022)
Figure 56. Merck KGaA Revenue Growth Rate in Nucleic Acid-Based Diagnostic Business (2017-2022)
Figure 57. Qiagen Revenue Growth Rate in Nucleic Acid-Based Diagnostic Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs